Elevated prolactin to cortisol ratio and polyclonal autoimmune activation in Hashimoto's thyroiditis

Hormone and Metabolic Research

Volumn 33, Issue 10, 2001, Pages 585-589

  Legakis, I ^a   Petroyianni, V ^b   Saramantis, A ^b   Tolis, G ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b Institute of Medical Technology   (Greece)

Author keywords

Autoantibodies; Cortisol; Hashimoto's Disease; Prolactin

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA; HYDROCORTISONE; MITOCHONDRIAL DNA; PROLACTIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOMODULATION; MALE; NUCLEOLUS; POLYCLONAL ACTIVATION; PREVALENCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SMOOTH MUSCLE; STOMACH PARIETAL CELL;

ADULT; AGED; AUTOANTIBODIES; FEMALE; HUMANS; HYDROCORTISONE; IODIDE PEROXIDASE; MALE; MIDDLE AGED; PROLACTIN; SEROEPIDEMIOLOGIC STUDIES; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 0034749326     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17904     Document Type: Article

References (37)

1. Prolactin and neuroimmunomodulation in vitro and in vivo observations
2. Functional characterization of the intermediate isoform of the human prolactin receptor
3. From the molecular biology of prolactin and its receptor to lessons learned from knock out mice models
4. The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome
5. Hyperprolactinemia in males with systemic lupus erythematosus
6. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases
7. Plasma cytokine concentration and the cytokine producing whole blood cell cultures from healthy females with pharmacologically induced hyperprolactinemia
8. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma
9. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus
10. Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases
11. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation
12. Effect of bromocriptine in patients with active rheumatoid arthritis
13. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity
14. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease
15. Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity
16. Hypofunction of the stress axis in Sjorgen's syndrome
17. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats
18. Mechanisms of cytokine signal transduction: IL-2, IL-4 and prolactin as hematopoietic receptor models
19. Effect of lipopolysacharide of tumor necrosis factor and prolactin release from fat rat anterior pituitary cells
20. Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats
21. Prolonged effects of tumor necrosis factor alpha on anterior pituitary hormone release
22. Prevalence of non-thyroid specific autoantibodies in autoimmune thyroid disease
23. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease
24. Elevation of anti-DNA antibody titer during thyrotoxic phase of silent thyroiditis
25. Increase in antideoxyribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease
26. Dynamic regulation of gastric autoimmunity by thyroid hormone
27. Autoantibodies in children
28. Diagnostic value of autoantibodies against microsomal thyroid peroxidase (anti-TPO)
29. Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TOP (thyroid microsomal) autoantibodies
30. Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity
31. New aspects of thyroid immunity
32. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: Relationship to antithyroperoxidase antibodies
33. Expression of the autoreactive Ig repertoire in a large family with high prevalence of thyroid autoimmune diseases
34. Cloning and analysis of IgG kappa and IgE lambda anti-thyroglobulin autoantibodies from a patient with Hashimoto's thyroiditis: Evidence for in vivo antigen-driven repertoire selection
35. Thyroid antibodies in northern Norway: Prevalence persistence and relevance
36. Anti-thyroglobulin autoantibodies in sera from patients with chronic thyroiditis and from healthy subjects: Differences in cross-reactivity with thyroid peroxidase
37. Enzyme-linked immunosorbent assay (ELISA) for IgG antibodies to thyroglobulin